The National Institutes of Health (NIH) has posted a grant opportunity titled "Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)". This grant aims to support and advance the Mutant Mouse Resource and Research Centers (MMRRC), which play a crucial role in biomedical research. The MMRRC consortium is responsible for identifying, acquiring, evaluating, characterizing, cryopreserving, and distributing mutant mouse strains to qualified biomedical investigators. These mutant mouse strains, along with related biomaterials, are used by researchers for various studies.
The MMRRC consists of a regional network of four centers and an Informatics, Coordination and Service Center (ICSC). Together, they serve the needs of the biomedical research community by providing transgenic, knockout, and other genetically-engineered mutant mice. The MMRRC ensures that all strains meet high standards to optimize reproducibility of studies and maintain scientific rigor and transparency. Each MMRRC is also required to develop a small high-risk, high-return research pilot project that aligns with the goals and needs of the consortium.
Small businesses are eligible to apply for this grant opportunity. However, non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. For more information on eligibility criteria, please refer to the full Notice of Funding Opportunity.
The deadline for submitting applications is September 1, 2024. Interested applicants can find additional information and apply through the following link: http://grants.nih.gov/grants/guide/pa-files/PAR-24-105.html. For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.